Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors

Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors

Considering the unrecognised physio-pathological role of human carbonic anhydrase III (hCA III), a structure-based drug design was set up to identify the first-in-class potent and selective inhibitors of this neglected isoform. hCA III targeting was planned considering a unique feature of its active...

Full description

Bibliographic Details
Main Authors: Simone Giovannuzzi, Alessandro Bonardi, Paola Gratteri, Alessio Nocentini, Claudiu T. Supuran
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:
Drug design
metalloenzyme
inhibition
click chemistry
hCA III
molecular dynamics
Online Access:https://www.tandfonline.com/doi/10.1080/14756366.2023.2202360

Internet

https://www.tandfonline.com/doi/10.1080/14756366.2023.2202360

Similar Items